Licensing agreement with Innovacell


Our attorneys advised European specialty pharmaceutical company Norgine B.V. on a collaboration and exclusive licensing agreement with Austria-based biotech company Innovacell regarding Innovacell's personalized cell-based therapy ICEF15. The agreement covered Europe, the Middle East, North Africa, and Southern Africa. Through the collaboration Norgine will co-develop ICEF15 with Innovacell, and Norgine will commercialize the product.

Email Disclaimer